United States Polypeptide Drug Market Report 2017

February 2017 | 121 pages | ID: U3CBC389891EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Polypeptide Drug

Revenue, means the sales value of Polypeptide Drug

This report studies sales (consumption) of Polypeptide Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Merck Serono
• Ferring Pharmaceuticals
• Ipsen PHarma Biotech
• Lilly
• Asahi Kasei
• AstraZeneca
• SciClone Pharmaceuticals
• Takeda

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Polypeptide Drug in each application, can be divided into

• Application 1
• Application 2

Contents

United States Polypeptide Drug Market Report 2017

1 POLYPEPTIDE DRUG OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Polypeptide Drug
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Polypeptide Drug (2012-2022)
  1.4.1 United States Polypeptide Drug Sales and Growth Rate (2012-2022)
  1.4.2 United States Polypeptide Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES POLYPEPTIDE DRUG COMPETITION BY MANUFACTURERS

2.1 United States Polypeptide Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Polypeptide Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Polypeptide Drug Average Price by Manufactures (2015 and 2016)
2.4 Polypeptide Drug Market Competitive Situation and Trends
  2.4.1 Polypeptide Drug Market Concentration Rate
  2.4.2 Polypeptide Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES POLYPEPTIDE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Polypeptide Drug Sales and Market Share by States (2012-2017)
3.2 United States Polypeptide Drug Revenue and Market Share by States (2012-2017)
3.3 United States Polypeptide Drug Price by States (2012-2017)

4 UNITED STATES POLYPEPTIDE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Polypeptide Drug Sales and Market Share by Type (2012-2017)
4.2 United States Polypeptide Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Polypeptide Drug Price by Type (2012-2017)
4.4 United States Polypeptide Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES POLYPEPTIDE DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Polypeptide Drug Sales and Market Share by Application (2012-2017)
5.2 United States Polypeptide Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES POLYPEPTIDE DRUG MANUFACTURERS PROFILES/ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Polypeptide Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck Serono
  6.2.2 Polypeptide Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Ferring Pharmaceuticals
  6.3.2 Polypeptide Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Ipsen PHarma Biotech
  6.4.2 Polypeptide Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Lilly
  6.5.2 Polypeptide Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Asahi Kasei
  6.6.2 Polypeptide Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.2 Polypeptide Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 SciClone Pharmaceuticals
  6.8.2 Polypeptide Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Takeda
  6.9.2 Polypeptide Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

7.1 Polypeptide Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Polypeptide Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Polypeptide Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES POLYPEPTIDE DRUG MARKET FORECAST (2017-2022)

11.1 United States Polypeptide Drug Sales, Revenue Forecast (2017-2022)
11.2 United States Polypeptide Drug Sales Forecast by Type (2017-2022)
11.3 United States Polypeptide Drug Sales Forecast by Application (2017-2022)
11.4 Polypeptide Drug Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Polypeptide Drug
Table Classification of Polypeptide Drug
Figure United States Sales Market Share of Polypeptide Drug by Type in 2015
Table Application of Polypeptide Drug
Figure United States Sales Market Share of Polypeptide Drug by Application in 2015
Figure United States Polypeptide Drug Sales and Growth Rate (2012-2022)
Figure United States Polypeptide Drug Revenue and Growth Rate (2012-2022)
Table United States Polypeptide Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Polypeptide Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Polypeptide Drug Sales Share by Manufacturers
Figure 2016 Polypeptide Drug Sales Share by Manufacturers
Table United States Polypeptide Drug Revenue by Manufacturers (2015 and 2016)
Table United States Polypeptide Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Polypeptide Drug Revenue Share by Manufacturers
Table 2016 United States Polypeptide Drug Revenue Share by Manufacturers
Table United States Market Polypeptide Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Polypeptide Drug Average Price of Key Manufacturers in 2015
Figure Polypeptide Drug Market Share of Top 3 Manufacturers
Figure Polypeptide Drug Market Share of Top 5 Manufacturers
Table United States Polypeptide Drug Sales by States (2012-2017)
Table United States Polypeptide Drug Sales Share by States (2012-2017)
Figure United States Polypeptide Drug Sales Market Share by States in 2015
Table United States Polypeptide Drug Revenue and Market Share by States (2012-2017)
Table United States Polypeptide Drug Revenue Share by States (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by States (2012-2017)
Table United States Polypeptide Drug Price by States (2012-2017)
Table United States Polypeptide Drug Sales by Type (2012-2017)
Table United States Polypeptide Drug Sales Share by Type (2012-2017)
Figure United States Polypeptide Drug Sales Market Share by Type in 2015
Table United States Polypeptide Drug Revenue and Market Share by Type (2012-2017)
Table United States Polypeptide Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Type (2012-2017)
Table United States Polypeptide Drug Price by Type (2012-2017)
Figure United States Polypeptide Drug Sales Growth Rate by Type (2012-2017)
Table United States Polypeptide Drug Sales by Application (2012-2017)
Table United States Polypeptide Drug Sales Market Share by Application (2012-2017)
Figure United States Polypeptide Drug Sales Market Share by Application in 2015
Table United States Polypeptide Drug Sales Growth Rate by Application (2012-2017)
Figure United States Polypeptide Drug Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Polypeptide Drug Sales Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Serono Polypeptide Drug Sales Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ferring Pharmaceuticals Polypeptide Drug Sales Market Share (2012-2017)
Table Ipsen PHarma Biotech Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ipsen PHarma Biotech Polypeptide Drug Sales Market Share (2012-2017)
Table Lilly Basic Information List
Table Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Lilly Polypeptide Drug Sales Market Share (2012-2017)
Table Asahi Kasei Basic Information List
Table Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Asahi Kasei Polypeptide Drug Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Polypeptide Drug Sales Market Share (2012-2017)
Table SciClone Pharmaceuticals Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table SciClone Pharmaceuticals Polypeptide Drug Sales Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Polypeptide Drug Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure United States Polypeptide Drug Production and Growth Rate Forecast (2017-2022)
Figure United States Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Table United States Polypeptide Drug Production Forecast by Type (2017-2022)
Table United States Polypeptide Drug Consumption Forecast by Application (2017-2022)
Table United States Polypeptide Drug Sales Forecast by States (2017-2022)
Table United States Polypeptide Drug Sales Share Forecast by States (2017-2022)